Home The Word Brain My Amedeo FAQ Privacy About   


C49

In our changing world, speaking just English isn't enough. Open new doors with skills in another world language.

Start with 7 words a day.

Next week: +49.


  Breast Cancer

  Free Subscription


Articles published in Nat Rev Clin Oncol

Retrieve available abstracts of 11 articles:
HTML format



Single Articles


    January 2025
  1. SIDAWAY P
    Women with clinically node negative breast cancer can safely avoid axillary surgery.
    Nat Rev Clin Oncol. 2025 Jan 3. doi: 10.1038/s41571-024-00982.
    PubMed    


    November 2024
  2. KILLOCK D
    First-line triplet therapy for advanced-stage PIK3CA-mutant HR(+) breast cancer improves outcomes.
    Nat Rev Clin Oncol. 2024 Nov 12. doi: 10.1038/s41571-024-00968.
    PubMed    


  3. DRAGO J, Modi S
    Expanding the use of T-DXd in metastatic HR-positive breast cancer: where are we now?
    Nat Rev Clin Oncol. 2024 Nov 6. doi: 10.1038/s41571-024-00963.
    PubMed    


  4. WAKS AG, Martinez-Saez O, Tarantino P, Braso-Maristany F, et al
    Dual HER2 inhibition: mechanisms of synergy, patient selection, and resistance.
    Nat Rev Clin Oncol. 2024;21:818-832.
    PubMed     Abstract available


    August 2024
  5. LLOYD MR, Jhaveri K, Kalinsky K, Bardia A, et al
    Precision therapeutics and emerging strategies for HR-positive metastatic breast cancer.
    Nat Rev Clin Oncol. 2024 Aug 23. doi: 10.1038/s41571-024-00935.
    PubMed     Abstract available


  6. MARRA A, Chandarlapaty S, Modi S
    Author Correction: Management of patients with advanced-stage HER2-positive breast cancer: current evidence and future perspectives.
    Nat Rev Clin Oncol. 2024 Aug 2. doi: 10.1038/s41571-024-00933.
    PubMed    


    July 2024
  7. YOON J, Oh DY
    HER2-targeted therapies beyond breast cancer - an update.
    Nat Rev Clin Oncol. 2024 Jul 22. doi: 10.1038/s41571-024-00924.
    PubMed     Abstract available


    June 2024
  8. KILLOCK D
    ALND can be safely omitted for patients with sentinel-node macrometastases.
    Nat Rev Clin Oncol. 2024;21:402.
    PubMed    


    May 2024
  9. DIECI MV, Guarneri V
    Gaining ground in personalized breast cancer therapy: lesson learned from PHERGain.
    Nat Rev Clin Oncol. 2024 May 22. doi: 10.1038/s41571-024-00907.
    PubMed    


    April 2024
  10. SIDAWAY P
    KN046 shows tolerability and activity in TNBC.
    Nat Rev Clin Oncol. 2024;21:251.
    PubMed    


    March 2024
  11. KONTOS D
    The promise of AI in personalized breast cancer screening: are we there yet?
    Nat Rev Clin Oncol. 2024 Mar 12. doi: 10.1038/s41571-024-00877.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.